title: Vancomycin syringe study shows significant reduction in dosing variability after introducing a revised protocol.
authors.affiliation: Laboratoire de Biopharmacie, Pharmacie Galénique et Hospitalière, EA4481, Université Lille Nord de France, Lille, France.
authors.forename: Aurélie
authors.initials: A
authors.lastname: Foinard
authors.forename: Bertrand
authors.initials: B
authors.lastname: Décaudin
authors.forename: Nicolas
authors.initials: N
authors.lastname: Simon
authors.forename: Christine
authors.initials: C
authors.lastname: Barthélémy
authors.forename: Laurent
authors.initials: L
authors.lastname: Storme
authors.forename: Pascal
authors.initials: P
authors.lastname: Odou
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004339:Drug Compounding; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D014640:Vancomycin / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin